Related Experiment Videos
[Exercise-induced bronchospasm and its prevention]
J Macan1, T Klepac, I Busljeta
1Institut za medicinska istrazivanja i medicinu rada, Ksaverska cesta 2, 10000 Zagreb.
Lijecnicki Vjesnik
|February 24, 2001
Summary
Exercise-induced bronchospasm (EIB) is airway hyperreactivity affecting many, even non-asthmatics. Proper diagnosis and treatment, including medication, help manage EIB symptoms for continued physical activity.
Area of Science:
- Pulmonary Medicine
- Allergology
- Sports Medicine
Context:
- Exercise-induced bronchospasm (EIB) is a common condition characterized by nonspecific bronchial hyperreactivity.
- It affects a significant portion of individuals with asthma and allergic rhinitis, and also occurs in a smaller percentage of the nonasthmatic population.
- The exact pathophysiology of EIB remains unclear, with theories involving bronchial epithelial hyperosmolarity, airway heat and water exchange, and reflex vagal bronchospasm.
Purpose:
- To review the current understanding of exercise-induced bronchospasm (EIB), including its prevalence, pathophysiology, diagnosis, and management.
- To highlight the impact of unrecognized EIB on physical activity and the importance of effective therapeutic strategies.
Summary:
- EIB affects a broad population, including children and young adults, with varying degrees of asthma and allergic rhinitis.
- Diagnosis involves medical history and standardized exercise testing with pulmonary function tests.
- Management focuses on non-pharmacological and pharmacological prophylactic measures, with inhaled beta-2-agonists and cromolyns being primary choices for prevention.
Impact:
- Effective management of EIB allows individuals to maintain everyday activities and participate in sports.
- Early diagnosis and treatment are crucial to prevent avoidance of physical activities.
- Further research into EIB pathophysiology may lead to improved therapeutic interventions.